[1]
J. Freeman, “Evidence from randomized clinical trials demonstrating improved glycemic control with GLP-1 receptor agonists when used with other agents vs other combination therapy strategies”, OFP, vol. 5, no. 1, pp. 43–50, Jan. 2013.